Jinghe Lang

497 total citations
24 papers, 307 citations indexed

About

Jinghe Lang is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Jinghe Lang has authored 24 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Reproductive Medicine, 12 papers in Obstetrics and Gynecology and 5 papers in Molecular Biology. Recurrent topics in Jinghe Lang's work include Ovarian cancer diagnosis and treatment (24 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Endometriosis Research and Treatment (5 papers). Jinghe Lang is often cited by papers focused on Ovarian cancer diagnosis and treatment (24 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Endometriosis Research and Treatment (5 papers). Jinghe Lang collaborates with scholars based in China, United States and Germany. Jinghe Lang's co-authors include Pao-Chen Wu, Ming Wu, Keng Shen, Dongyan Cao, Jiaxin Yang, Yan You, Jie Chen, Qian Chen, Shu Wang and Shuang Ye and has published in prestigious journals such as PLoS ONE, American Journal of Obstetrics and Gynecology and Medicine.

In The Last Decade

Jinghe Lang

22 papers receiving 295 citations

Peers

Jinghe Lang
Kevin L. Hall United States
Gordon O. Downey United States
Noah A. Goldman United States
Donald H. Chamberlain United States
Sinikka Oksa Finland
Kevin L. Hall United States
Jinghe Lang
Citations per year, relative to Jinghe Lang Jinghe Lang (= 1×) peers Kevin L. Hall

Countries citing papers authored by Jinghe Lang

Since Specialization
Citations

This map shows the geographic impact of Jinghe Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinghe Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinghe Lang more than expected).

Fields of papers citing papers by Jinghe Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinghe Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinghe Lang. The network helps show where Jinghe Lang may publish in the future.

Co-authorship network of co-authors of Jinghe Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinghe Lang. A scholar is included among the top collaborators of Jinghe Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinghe Lang. Jinghe Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Yifan, Ning Li, Yilin Xu, et al.. (2024). Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017. EClinicalMedicine. 79. 102983–102983. 7 indexed citations
2.
Liu, Qian, Zhiqiang Li, Dongyan Cao, et al.. (2024). Clinicopathological features and surgical procedures of adnexal masses with abdominal pain in pediatric and adolescent patients. Orphanet Journal of Rare Diseases. 19(1). 132–132. 1 indexed citations
3.
Li, Lei & Jinghe Lang. (2024). Recent advances in the treatment for gynecologic oncology. 3(1).
4.
Chen, Qian, et al.. (2021). Clinical characteristics and prognostic factors of stage IC ovarian clear cell carcinoma: a Surveillance, Epidemiology, and End Results (SEER) analysis. Archives of Gynecology and Obstetrics. 304(2). 521–529. 5 indexed citations
5.
Lang, Jinghe, et al.. (2020). Survival Analysis of Lymph Node Resection in Ovarian Cancer: A Population-Based Study. Frontiers in Oncology. 10. 355–355. 11 indexed citations
6.
Hu, Yingchao, Lejia Sun, Yinglan Zhang, Jinghe Lang, & Jun Rao. (2020). <p>Phosphoproteomics Reveals Key Regulatory Kinases and Modulated Pathways Associated with Ovarian Cancer Tumors</p>. OncoTargets and Therapy. Volume 13. 3595–3605. 4 indexed citations
7.
Chen, Qian, Shu Wang, & Jinghe Lang. (2020). Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma. Journal of Ovarian Research. 13(1). 123–123. 17 indexed citations
8.
Li, Sijian, Xiaoyan Li, Limeng Zhang, et al.. (2020). FIGO Stage IV and Age Over 55 Years as Prognostic Predicators in Patients With Metastatic Malignant Struma Ovarii. Frontiers in Oncology. 10. 584917–584917. 14 indexed citations
9.
Li, Lei, et al.. (2019). The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas. Archives of Gynecology and Obstetrics. 300(4). 1045–1052. 11 indexed citations
10.
Li, Lei, et al.. (2019). Pathological findings following risk-reducing salpingo-oophorectomy in BRCA mutation carriers: A systematic review and meta-analysis. European Journal of Surgical Oncology. 46(1). 139–147. 6 indexed citations
11.
Lang, Jinghe, et al.. (2019). Laparoscopic “Core-Pulling” Salpingectomy: A Novel and Minimally Invasive Modified Salpingectomy. International Surgery. 104(5-6). 255–261.
12.
Sun, Tingting, Shu Wang, Jian Sun, et al.. (2018). Clinical analysis of chemo-resistance risk factors in endometriosis associated ovarian cancer. Journal of Ovarian Research. 11(1). 40–40. 7 indexed citations
13.
Ye, Shuang, Jiaxin Yang, Dongyan Cao, et al.. (2015). Characteristic and Prognostic Implication of Venous Thromboembolism in Ovarian Clear Cell Carcinoma: A 12-Year Retrospective Study. PLoS ONE. 10(3). e0121818–e0121818. 23 indexed citations
14.
Ye, Shuang, Jiaxin Yang, Yan You, et al.. (2015). Comparison of Clinical Characteristic and Prognosis between Ovarian Clear Cell Carcinoma and Serous Carcinoma: A 10-Year Cohort Study of Chinese Patients. PLoS ONE. 10(7). e0133498–e0133498. 15 indexed citations
15.
You, Yan, Jiaxin Yang, Dongyan Cao, et al.. (2015). Management and prognosis of patients with ovarian sex cord tumor with annular tubules: a retrospective study. BMC Cancer. 15(1). 270–270. 29 indexed citations
16.
Bai, Huimin, Dongyan Cao, Jiaxin Yang, et al.. (2015). Salvage Chemotherapy for Patients With Recurrent or Persistent Ovarian Clear Cell Carcinoma. Medicine. 94(27). e1121–e1121. 12 indexed citations
17.
Ye, Shuang, Yan You, Jiaxin Yang, et al.. (2014). Comparison of Pure and Mixed-Type Clear Cell Carcinoma of the Ovary. International Journal of Gynecological Cancer. 24(9). 1590–1596. 8 indexed citations
18.
Pan, Lingya, et al.. (2014). [Clinical study on 68 cases with struma ovarii].. PubMed. 49(6). 451–4. 7 indexed citations
19.
Cao, Dongyan, Keng Shen, Tao Tao, et al.. (2011). [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].. PubMed. 46(1). 15–8. 1 indexed citations
20.
Tan, Xianjie, et al.. (2008). [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].. PubMed. 43(1). 9–12. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026